Quotes Xcell Therapeutics Inc.

Equities

A373110

KR7373110006

Pharmaceuticals

End-of-day quote Korea S.E. 18:00:00 2024-07-14 EDT 5-day change 1st Jan Change
8,330 KRW -16.70% Intraday chart for Xcell Therapeutics Inc. 0.00% 0.00%

Quotes 5-day view

End-of-day quote Korea S.E.
  2024-07-15 Today
Last 8330 ₩ 8330 ₩
Volume 20 377 100 10 583 940
Change +∞% 0.00%
Opening 12,480.00 8,200.00
High 12,900.00 9,410.00
Low 8,330.00 8,000.00

Performance

1 day-16.70%

Volumes

markets
Daily volume
20 377 100
Record volume 1
20 377 100
Record volume 2
0
Record volume 3
0
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (KRW)
64 983 197
Capitalization (USD)
64 983 197
Free-Float
78.54 %
Free-Float capitalization (KRW)
51 267 582
Free-Float capitalization (USD)
51 267 582

Highs and lows

1 week
8 330.00
Extreme 8330
12 900.00
1 month
8 330.00
Extreme 8330
12 900.00
Current year
8 330.00
Extreme 8330
12 900.00
1 year
8 330.00
Extreme 8330
12 900.00
3 years
8 330.00
Extreme 8330
12 900.00
5 years
8 330.00
Extreme 8330
12 900.00
10 years
8 330.00
Extreme 8330
12 900.00

Indicators

RSI 9 days
0.00
RSI 14 days
0.00

Sector Comparison - Other Pharmaceuticals

Name Change 5d. change 1st Jan change 1-year change Capi.
-16.70%0.00% - - 64.98M
+0.38%+2.41%+63.83%+113.58% 856B
-0.26%+0.80%+39.48%+81.66% 631B
+0.54%+2.26%-4.06%-5.47% 359B
-0.13%+1.93%+17.84%+21.69% 325B
+0.18%+0.40%+8.88%+25.14% 297B
+0.02%+5.76%+5.81%-3.54% 234B
-0.17%+1.98%+16.66%+16.59% 226B
+0.67%+5.87%+16.13%+46.80% 177B
+1.19%+6.13%+2.19%-17.96% 165B
-0.56%-0.13%+2.40%-2.39% 126B
+1.52%+6.21%-11.16%-7.11% 88.22B
+1.46%-0.29%-20.60%-34.13% 81.39B
+0.18%-0.56%+3.54%+13.87% 79.32B
+0.43%+2.31%+55.29%+54.06% 72.41B
-3.50%-3.55%+13.52%+55.17% 65.5B
Average-0.92%+2.27%+13.98%+23.86%
Weighted average by Cap.+0.17%+2.26%+25.82%+46.13%

Historical data

DateOpeningHighLowEnd-of-dayVolume
Chart Xcell Therapeutics Inc.
More charts

Monthly variations

Annual change

20240.00%
  1. Stock Market
  2. Equities
  3. A373110 Stock
  4. Quotes Xcell Therapeutics Inc.